Lhériteau et al. provided great promise for human treatment: gene addition therapy can restore the functional deficit of cone photoreceptors and prevent the retinal degeneration and vision loss in RPGRIP1-deficient dogs, a model exhibiting a severe cone-rod dystrophy similar to that seen in humans [22]. Here, RPGRIP1 is linked to cone-rod dystrophy.